Is it safe to take Vyvanse (lisdexamfetamine) 50mg and Dexedrine (dextroamphetamine) 5mg at 7:00am and Dexedrine (dextroamphetamine) 5mg at 2:00pm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can This Combination Be Taken Safely?

Yes, taking Vyvanse 50mg plus Dexedrine 5mg at 7:00am, followed by Dexedrine 5mg at 2:00pm is safe and clinically appropriate, as this totals 60mg of dextroamphetamine equivalent daily, which remains within established maximum dosing limits. 1, 2

Total Daily Amphetamine Dose Calculation

  • Vyvanse 50mg converts to approximately 20mg of dextroamphetamine after enzymatic hydrolysis in the blood 3
  • Adding the two 5mg Dexedrine doses yields a total of approximately 30mg dextroamphetamine equivalent daily
  • The American Academy of Child and Adolescent Psychiatry establishes a maximum daily dose of 50mg for Adderall (mixed amphetamine salts), with some guidelines supporting up to 50-70mg total daily amphetamine dose for adults requiring extended coverage 1, 2
  • Your proposed regimen falls comfortably within these limits 1, 2

Timing Considerations

  • The 7:00am dosing of both medications together is appropriate, as Vyvanse reaches peak dextroamphetamine levels at approximately 3.5 hours post-dose, providing morning coverage 3
  • The 2:00pm Dexedrine dose follows established guidelines that recommend giving the second stimulant dose preferably no later than 2:00pm to minimize insomnia risk 4, 2, 5
  • The National Comprehensive Cancer Network specifically recommends that methylphenidate or dextroamphetamine's second dose should be given at lunch, preferably no later than 2:00pm 4, 5

Pharmacokinetic Rationale

  • Vyvanse is a prodrug that requires enzymatic hydrolysis in red blood cells to release active dextroamphetamine, with a plasma elimination half-life of dextroamphetamine of approximately 10-11.3 hours in adults 3
  • The immediate-release Dexedrine at 7:00am provides rapid symptom control while Vyvanse undergoes conversion 3
  • The 2:00pm Dexedrine dose extends coverage into late afternoon/early evening without significantly interfering with sleep, given the timing cutoff 4, 2

Required Monitoring

  • Check blood pressure and pulse quarterly, as small mean increases are expected with amphetamine therapy 2, 6
  • Monitor weight at every visit to detect appetite suppression, which occurs in 25-39% of patients 2, 6
  • Assess target ADHD symptoms using standardized rating scales at each visit 2
  • Document side effects including insomnia, anorexia, headaches, irritability, anxiety, and tics 2, 6

Common Pitfalls to Avoid

  • Do not administer the afternoon Dexedrine dose later than 2:00pm, as this increases insomnia risk 4, 2, 5
  • Avoid escalating beyond maximum recommended total daily doses if tolerance develops; instead consider medication holidays or switching agents 2
  • Do not crush or open Vyvanse capsules to attempt faster onset, as this destroys the prodrug mechanism and can cause dangerous immediate release 1

When This Regimen May Not Be Appropriate

  • Active substance use disorder represents a relative contraindication to this combination 2
  • Cardiovascular risk factors such as hypertension or structural cardiac abnormalities require careful evaluation before initiating 2
  • Prohibitive side effects at lower doses should prompt consideration of alternative treatments rather than this combination 2

Documentation Best Practices

  • Clearly state previous doses attempted and why they were insufficient 2
  • Document current symptom severity using objective rating scales 2
  • Note the absence of prohibitive side effects at the current dose 2
  • Record blood pressure, pulse, and weight measurements at each visit 2

References

Guideline

Maximum Recommended Doses of Adderall XR and IR for ADHD

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Adderall XR and IR Combination Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Timing of CNS Stimulant Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.